To investigate the pharmacodynamic effects of combining gefitinib and BYL719 in vivo, tumor lysates of PC-9-PIK3CA-M xenografts were collected at the final day, and were analyzed for PI3K/AKT expression by western blot and IHC. This evidence concerns the gene PIK3CB and neoplasm.